23.20
-1.20
(-4.92%)
At close: April 10 at 9:55:01 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 7 |
| Avg. Estimate | 201.31M | 201.05M | 817.24M | 867.59M |
| Low Estimate | 198.8M | 198.03M | 803.34M | 840.97M |
| High Estimate | 206.19M | 206.22M | 838.54M | 914.32M |
| Year Ago Sales | 211.28M | 204.74M | 825.86M | 817.24M |
| Sales Growth (year/est) | -4.72% | -1.80% | -1.04% | 6.16% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HQS.F | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Initiated | Jefferies: Buy | 3/17/2025 |
| Maintains | Truist Securities: Buy to Buy | 2/13/2025 |
| Maintains | Mizuho: Neutral to Neutral | 1/7/2025 |
| Maintains | Jefferies: Hold to Hold | 1/2/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 11/4/2024 |
| Maintains | Baird: Neutral to Neutral | 11/1/2024 |